133 related articles for article (PubMed ID: 30123055)
1. Correlation between
Hu GN; Tzeng HE; Chen PC; Wang CQ; Zhao YM; Wang Y; Su CM; Tang CH
Int J Med Sci; 2018; 15(11):1179-1186. PubMed ID: 30123055
[TBL] [Abstract][Full Text] [Related]
2. Chemokine C-C Motif Ligand 4 Gene Polymorphisms Associated with Susceptibility to Rheumatoid Arthritis.
Kuo SJ; Huang CC; Tsai CH; Hsu HC; Su CM; Tang CH
Biomed Res Int; 2018; 2018():9181647. PubMed ID: 29955612
[TBL] [Abstract][Full Text] [Related]
3. Impact of CCL4 gene polymorphisms and environmental factors on oral cancer development and clinical characteristics.
Lien MY; Lin CW; Tsai HC; Chen YT; Tsai MH; Hua CH; Yang SF; Tang CH
Oncotarget; 2017 May; 8(19):31424-31434. PubMed ID: 28404909
[TBL] [Abstract][Full Text] [Related]
4. Impact of CCL4 gene polymorphisms upon the progression of lung cancer in a Han Chinese cohort.
Hu W; Chien SY; Ying P; Liu PI; Su CM; Tang CH
Medicine (Baltimore); 2020 Jan; 99(3):e18906. PubMed ID: 32011520
[TBL] [Abstract][Full Text] [Related]
5. Impacts of CCL4 gene polymorphisms on hepatocellular carcinoma susceptibility and development.
Wang B; Chou YE; Lien MY; Su CM; Yang SF; Tang CH
Int J Med Sci; 2017; 14(9):880-884. PubMed ID: 28824325
[TBL] [Abstract][Full Text] [Related]
6.
Huang BF; Tzeng HE; Chen PC; Wang CQ; Su CM; Wang Y; Hu GN; Zhao YM; Wang Q; Tang CH
Int J Med Sci; 2018; 15(6):580-586. PubMed ID: 29725248
[TBL] [Abstract][Full Text] [Related]
7. The Association of CCL4 rs1634507 and rs10491121 Polymorphisms with Susceptibility of Oral Squamous Cell Carcinoma in an Iranian Population: A Case-Control Study.
Kadeh H; Eyni M; Parsasefat M; Miri-Moghaddam E
Iran J Pathol; 2022; 17(2):210-216. PubMed ID: 35463731
[TBL] [Abstract][Full Text] [Related]
8. [Association of CD44 polymorphisms with genetic susceptibilities and clinico-pathologic characteristics in breast cancer].
Zhou X; Wu CY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):807-11. PubMed ID: 23387202
[TBL] [Abstract][Full Text] [Related]
9. [Association of single nucleotide polymorphisms in PAI-1 with breast cancer susceptibility and prognosis].
Chen YL; Jia YM; Xie YT; Li Y; Fang WG; Tian XX
Zhonghua Bing Li Xue Za Zhi; 2016 Aug; 45(8):533-9. PubMed ID: 27510778
[TBL] [Abstract][Full Text] [Related]
10. Risk of aggressive breast cancer in women of Han nationality carrying TGFB1 rs1982073 C allele and FGFR2 rs1219648 G allele in North China.
Chen XH; Li XQ; Chen Y; Feng YM
Breast Cancer Res Treat; 2011 Jan; 125(2):575-82. PubMed ID: 20640597
[TBL] [Abstract][Full Text] [Related]
11. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
Curtit E; Pivot X; Henriques J; Paget-Bailly S; Fumoleau P; Rios M; Bonnefoi H; Bachelot T; Soulié P; Jouannaud C; Bourgeois H; Petit T; Tennevet I; Assouline D; Mathieu MC; Jacquin JP; Lavau-Denes S; Darut-Jouve A; Ferrero JM; Tarpin C; Lévy C; Delecroix V; Trillet-Lenoir V; Cojocarasu O; Meunier J; Pierga JY; Kerbrat P; Faure-Mercier C; Blanché H; Sahbatou M; Boland A; Bacq D; Besse C; Thomas G; Deleuze JF; Pauporté I; Romieu G; Cox DG
Breast Cancer Res; 2017 Aug; 19(1):98. PubMed ID: 28830573
[TBL] [Abstract][Full Text] [Related]
13. FSCN1 gene polymorphisms: biomarkers for the development and progression of breast cancer.
Wang CQ; Tang CH; Wang Y; Jin L; Wang Q; Li X; Hu GN; Huang BF; Zhao YM; Su CM
Sci Rep; 2017 Nov; 7(1):15887. PubMed ID: 29162880
[TBL] [Abstract][Full Text] [Related]
14. [Association between single nucleotide polymorphisms of BARD 1 gene and susceptibility of early-onset breast cancer in Uygur women in Xinjiang].
Sun G; Wang JT; Ma BL; Geng ZL; Ren GH; Shan MH; Ma B; Ma LL; Wang Y
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):341-7. PubMed ID: 22883453
[TBL] [Abstract][Full Text] [Related]
15. LFA-1 gene polymorphisms are associated with the sporadic infiltrative duct breast carcinoma in Chinese Han women of Heilongjiang Province.
Fu Z; Jiao M; Zhang M; Xu F; Yuan W; Pang D; Li D
Breast Cancer Res Treat; 2011 May; 127(1):265-71. PubMed ID: 20953905
[TBL] [Abstract][Full Text] [Related]
16. Impact of WNT1-inducible signaling pathway protein-1 (WISP-1) genetic polymorphisms and clinical aspects of breast cancer.
Wang Y; Yang SH; Hsu PW; Chien SY; Wang CQ; Su CM; Dong XF; Zhao YM; Tang CH
Medicine (Baltimore); 2019 Nov; 98(44):e17854. PubMed ID: 31689877
[TBL] [Abstract][Full Text] [Related]
17. [Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility].
Wang ML; Xu YX; Qian J; Wang FH
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):124-8. PubMed ID: 23719102
[TBL] [Abstract][Full Text] [Related]
18. Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk.
Langsenlehner U; Renner W; Yazdani-Biuki B; Eder T; Wascher TC; Paulweber B; Clar H; Hofmann G; Samonigg H; Krippl P
Breast Cancer Res Treat; 2006 May; 97(1):67-72. PubMed ID: 16317580
[TBL] [Abstract][Full Text] [Related]
19. Association of CCL4 rs10491121 and rs1634507 gene polymorphisms with cancer susceptibility: trial sequential analysis and meta-analysis.
Yang C; Song T; Mo Y; Wu P; Tian H; Wen L; Gao Y
Front Oncol; 2023; 13():1133055. PubMed ID: 37593100
[TBL] [Abstract][Full Text] [Related]
20. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
